#9: TheMachine: ACCOR: Solid 5.2% Like-For-Like Growth in First-Half 2008 Accor Revenue
Strong 5.1% Growth in the Hotels Business, Particularly in... |
July 22, 2008
07:15:43 AM |
#8: FastFun: Access Pharmaceuticals Demonstrates Ability to Significantly Reduce Glucose Levels in Pre-clinical Testing of Cobalamin(TM) Oral Insulin
DALLAS, Dec. 7 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc.... |
December 8, 2007
11:20:04 PM |
#7: FastFun: Access Pharmaceuticals' ProLindac(TM) to be Featured at the 10th International Symposium on Platinum Coordination Compounds in Cancer Chemotherapy Conference
DALLAS, Dec. 3 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc.... |
December 8, 2007
11:19:37 PM |
#6: FastFun: Access Pharmaceuticals Announces $19.5 Million Recapitalization
- $9.5 Million Institutional Private Placement -
- $10 Million... |
November 26, 2007
12:17:08 AM |
#5: FastFun: Access Pharmaceuticals Announces Two Poster Presentations Reporting Significant Preclinical Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference
DALLAS, Oct. 29 /PRNewswire-FirstCall/ -- ACCESS PHARMACEUTICALS, INC.... |
November 26, 2007
12:15:57 AM |
#4: FastFun: Access Pharmaceuticals Announces Presentation on ProLindac(TM) Phase 2 Study at AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference
ProLindac Shows Clinically Meaningful Stabilizations and Consistent... |
October 27, 2007
09:20:41 PM |
#3: FastFun: Access Pharmaceuticals to Present Data on ProLindac(TM) at the AACR-NCI-EORTC 'Molecular Targets and Cancer Therapeutics' Conference
DALLAS, Oct. 18 /PRNewswire-FirstCall/ -- Access Pharmaceuticals, Inc.... |
October 27, 2007
09:19:48 PM |
#2: FastFun: Access Highlighted in Recent BusinessWeek Article
Correction - Monday September 17, 9:00 am ET
DALLAS--(BUSINESS WIRE)--ACCESS... |
October 7, 2007
06:46:19 AM |
#1: Art: Cancer Drug status
ACCP has an excellent potential cancer treatment drug. Any inputs would be... |
September 18, 2007
03:56:47 PM |
